ArticlePLoS medicine2026
Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study.
Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding how respiratory infectious diseases spread across cities of different socioeconomic tiers is crucial for regionally targeted interventions. However, most spatial prediction frameworks neglect the combined influence of urban hierarchy and human mobility in shaping transmission risk. METHODS AND
findingsWe integrated large-scale intercity mobility data into an agent-based branching process model to simulate the spatial diffusion of respiratory pathogens across mainland China. Three COVID-19 outbreaks were used for validation: the Omicron outbreak in Shanghai, the Delta outbreak in Nanjing, and a multi-provincial Delta outbreak in northwestern China. We applied the framework to model the spread of SARS-CoV-2 (Omicron variant) and Influenza A to quantify tier-specific transmission risks. Tiers denote a hierarchical classification of Chinese cities based on concentration of commercial resources, transportation hub centrality, etc., ranging from super-tier metropolises to lower-tier cities. Predicted first arrival times showed strong agreement with observed data (r = 0.68 and 0.76), and mobility-based predictions more accurately identified outbreak origins than distance-based approaches. Markedly different tier-dependent diffusion patterns were observed across pathogens. Influenza A exhibited stable and stratified diffusion, with transmission confined mainly within the same or adjacent urban tiers and limited cross-tier seeding. In contrast, SARS-CoV-2 (Omicron) initially concentrated in super-tier and tier-1 cities but rapidly spread to lower-tier cities, producing a pronounced hierarchical pattern of spread that quickly diminished tier-level differences in transmission risk. Across pathogens, higher-tier cities consistently faced greater early importation risk; however, this disparity persisted for Influenza A but was rapidly attenuated for Omicron due to its high transmissibility and fast spatial expansion. A key limitation is that the model was validated against city-level first arrival times rather than full epidemic dynamics, and was parameterised using mobility data from China's "dynamic zero-COVID" period, which may limit direct quantitative generalisability to other settings.
conclusionsSpatial transmission risk reflects an interaction between pathogen-specific transmissibility and the hierarchical organisation of China's urban mobility system. These findings indicate that surveillance and response strategies effective for less transmissible pathogens may be insufficient for highly transmissible variants. Mobility-informed, tier-specific risk assessment may help inform early warning and support more adaptive public health responses. Because the framework relies on routinely available mobility data and minimal pathogen-specific inputs, it may provide a scalable approach for epidemic preparedness, including potential future emerging respiratory threats (Disease X).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.